Long non-coding RNAs in recurrent ovarian cancer: Theranostic perspectives
2021-07-19
Cancer Letters 502:97-107 Apr 2021 

Bhardwaj, Vipul; Tan, Yan Qin; Wu, Ming Ming; Ma, Lan; Zhu, Tao; Lobie, Peter E.; Pandey, Vijay

Abstract:

Nearly 70% of ovarian cancer (OC) patients experience recurrence within the first 2 years after initial treatment. Emerging evidence indicates that long non-coding RNAs (lncRNAs) play a pivotal role in the pathogenesis of OC progression, resistance to therapy and recurrent OC (ROC). Transcriptome profiling studies have reported differential expression patterns of lncRNAs in OC which are related to increased cell invasion, metastasis and drug resistance. In this review, we highlighted the roles of lncRNAs in OC progression and outlined the potential molecular mechanisms by which lncRNAs impact on ROC. Recent advances using lncRNAs as potential biomarkers for screening, detection, prediction, response to therapy and as therapeutic targets are discussed.

https://www.x-mol.com/paper/1348380065658724352?adv 


Last updated: Oct. 2021   |  Copyright © Hefei National Laboratory for Physical Sciences at the Microscale  |  Top  |  Site Map